BURLINGTON, Mass., March 1, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced that Dr. Bobby W. Sandage, Jr., Coronado’s President and CEO, will present at the Cowen and Co. 32nd Annual Health Care Conference on Monday, March 5, 2012 at 2:50 PM PT at the Marriott Copley Place in Boston. A webcast of the presentation will be available at www.coronadobiosciences.com on the Events & Webcasts page.
